PRODUCT LITERATURE
Docosahexaenoic Acid for Reading, Cognition and Behavior in Children Aged 7–9 Years: A Randomized, Controlled Trial (The DOLAB Study)
Omega-3 fatty acids are dietary essentials, and the current low intakes in most modern developed countries
are believed to contribute to a wide variety of physical and mental health problems. Evidence from clinical trials indicates
that dietary supplementation with long-chain omega-3 may improve child behavior and learning, although most previous
trials have involved children with neurodevelopmental disorders such as attention-deficit/hyperactivity disorder (ADHD) or
developmental coordination disorder (DCD). Here we investigated whether such benefits might extend to the general child
population
No other version available